Core Insights - Elutia Inc. is participating in Chardan's Trending Issues in Drug Development Conference Series on April 29, 2025, with Dr. Michelle LeRoux Williams as the Chief Scientific Officer [1] - The conference will be held in a virtual format, featuring a fireside chat at 11:00 a.m. ET, and a webcast will be available on Elutia's investor website [2] - Elutia focuses on developing and commercializing drug-eluting biomatrix products aimed at enhancing the compatibility of medical devices with patients [3] Company Overview - Elutia is dedicated to improving medical technology for a growing population that requires implantable devices, with a mission to humanize medicine [3] - The company emphasizes the importance of patient compatibility and aims to ensure that patients can thrive without compromise [3]
Elutia to Participate in Chardan's Trending Issues in Drug Development Conference Series on April 29